T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 26.73 CNY -2.05% Market Closed
Market Cap: 2.2B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Tongling Jieya Biologic Technology Co Ltd stock under the Base Case scenario is 22.94 CNY. Compared to the current market price of 26.73 CNY, Tongling Jieya Biologic Technology Co Ltd is Overvalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
22.94 CNY
Overvaluation 14%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation Backtest
Tongling Jieya Biologic Technology Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Tongling Jieya Biologic Technology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Tongling Jieya Biologic Technology Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Tongling Jieya Biologic Technology Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Tongling Jieya Biologic Technology Co Ltd

Provide an overview of the primary business activities
of Tongling Jieya Biologic Technology Co Ltd.

What unique competitive advantages
does Tongling Jieya Biologic Technology Co Ltd hold over its rivals?

What risks and challenges
does Tongling Jieya Biologic Technology Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Tongling Jieya Biologic Technology Co Ltd.

Provide P/S
for Tongling Jieya Biologic Technology Co Ltd.

Provide P/E
for Tongling Jieya Biologic Technology Co Ltd.

Provide P/OCF
for Tongling Jieya Biologic Technology Co Ltd.

Provide P/FCFE
for Tongling Jieya Biologic Technology Co Ltd.

Provide P/B
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/S
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/GP
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/EBITDA
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/EBIT
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/OCF
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/FCFF
for Tongling Jieya Biologic Technology Co Ltd.

Provide EV/IC
for Tongling Jieya Biologic Technology Co Ltd.

Show me price targets
for Tongling Jieya Biologic Technology Co Ltd made by professional analysts.

What are the Revenue projections
for Tongling Jieya Biologic Technology Co Ltd?

How accurate were the past Revenue estimates
for Tongling Jieya Biologic Technology Co Ltd?

What are the Net Income projections
for Tongling Jieya Biologic Technology Co Ltd?

How accurate were the past Net Income estimates
for Tongling Jieya Biologic Technology Co Ltd?

What are the EPS projections
for Tongling Jieya Biologic Technology Co Ltd?

How accurate were the past EPS estimates
for Tongling Jieya Biologic Technology Co Ltd?

What are the EBIT projections
for Tongling Jieya Biologic Technology Co Ltd?

How accurate were the past EBIT estimates
for Tongling Jieya Biologic Technology Co Ltd?

Compare the revenue forecasts
for Tongling Jieya Biologic Technology Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Tongling Jieya Biologic Technology Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Tongling Jieya Biologic Technology Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Tongling Jieya Biologic Technology Co Ltd compared to its peers.

Compare the P/E ratios
of Tongling Jieya Biologic Technology Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Tongling Jieya Biologic Technology Co Ltd with its peers.

Analyze the financial leverage
of Tongling Jieya Biologic Technology Co Ltd compared to its main competitors.

Show all profitability ratios
for Tongling Jieya Biologic Technology Co Ltd.

Provide ROE
for Tongling Jieya Biologic Technology Co Ltd.

Provide ROA
for Tongling Jieya Biologic Technology Co Ltd.

Provide ROIC
for Tongling Jieya Biologic Technology Co Ltd.

Provide ROCE
for Tongling Jieya Biologic Technology Co Ltd.

Provide Gross Margin
for Tongling Jieya Biologic Technology Co Ltd.

Provide Operating Margin
for Tongling Jieya Biologic Technology Co Ltd.

Provide Net Margin
for Tongling Jieya Biologic Technology Co Ltd.

Provide FCF Margin
for Tongling Jieya Biologic Technology Co Ltd.

Show all solvency ratios
for Tongling Jieya Biologic Technology Co Ltd.

Provide D/E Ratio
for Tongling Jieya Biologic Technology Co Ltd.

Provide D/A Ratio
for Tongling Jieya Biologic Technology Co Ltd.

Provide Interest Coverage Ratio
for Tongling Jieya Biologic Technology Co Ltd.

Provide Altman Z-Score Ratio
for Tongling Jieya Biologic Technology Co Ltd.

Provide Quick Ratio
for Tongling Jieya Biologic Technology Co Ltd.

Provide Current Ratio
for Tongling Jieya Biologic Technology Co Ltd.

Provide Cash Ratio
for Tongling Jieya Biologic Technology Co Ltd.

What is the historical Revenue growth
over the last 5 years for Tongling Jieya Biologic Technology Co Ltd?

What is the historical Net Income growth
over the last 5 years for Tongling Jieya Biologic Technology Co Ltd?

What is the current Free Cash Flow
of Tongling Jieya Biologic Technology Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Tongling Jieya Biologic Technology Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tongling Jieya Biologic Technology Co Ltd

Current Assets 1.6B
Cash & Short-Term Investments 1.1B
Receivables 173.8m
Other Current Assets 338.1m
Non-Current Assets 561.2m
Long-Term Investments 247.8m
PP&E 263.7m
Intangibles 35.3m
Other Non-Current Assets 14.5m
Current Liabilities 241.9m
Accounts Payable 123.6m
Accrued Liabilities 13.2m
Short-Term Debt 86.8m
Other Current Liabilities 18.3m
Non-Current Liabilities 48.2m
Long-Term Debt 9.6m
Other Non-Current Liabilities 38.6m
Efficiency

Earnings Waterfall
Tongling Jieya Biologic Technology Co Ltd

Revenue
624.4m CNY
Cost of Revenue
-469.7m CNY
Gross Profit
154.7m CNY
Operating Expenses
-86.7m CNY
Operating Income
68m CNY
Other Expenses
23.8m CNY
Net Income
91.8m CNY

Free Cash Flow Analysis
Tongling Jieya Biologic Technology Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tongling Jieya Biologic Technology Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Operating Income
56/100
Profitability
Score

Tongling Jieya Biologic Technology Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tongling Jieya Biologic Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Tongling Jieya Biologic Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tongling Jieya Biologic Technology Co Ltd

Wall Street analysts forecast Tongling Jieya Biologic Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tongling Jieya Biologic Technology Co Ltd is 35.7 CNY with a low forecast of 35.35 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
35.35 CNY
32% Upside
Average
Price Target
35.7 CNY
34% Upside
Highest
Price Target
36.75 CNY
37% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Tongling Jieya Biologic Technology Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tongling Jieya Biologic Technology Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Tongling Jieya Biologic Technology Co Ltd

Country

China

Industry

Consumer products

Market Cap

2.2B CNY

Dividend Yield

1.35%

Description

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Contact

ANHUI
Tongling
No. 528, Geological Avenue, Lion Mountain Economic Development Zone
+865626868001
www.babywipes.com.cn

IPO

2021-12-03

Employees

798

Officers

Chairman of the Board & GM
Mr. Yingchuan Cai
CFO & Director
Mr. Fanlong Yang
Deputy GM & Director
Ms. Ying Ye
Deputy GM & Board Secretary
Mr. Nenghua Hu

See Also

Discover More
What is the Intrinsic Value of one Tongling Jieya Biologic Technology Co Ltd stock?

The intrinsic value of one Tongling Jieya Biologic Technology Co Ltd stock under the Base Case scenario is 22.94 CNY.

Is Tongling Jieya Biologic Technology Co Ltd stock undervalued or overvalued?

Compared to the current market price of 26.73 CNY, Tongling Jieya Biologic Technology Co Ltd is Overvalued by 14%.

Back to Top